BioPlus Acquisition Corp. Unit
BIOSU
BIOSU was delisted on the 6th of October, 2023.
30 hedge funds and large institutions have $38.8M invested in BioPlus Acquisition Corp. Unit in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 52 closing their positions.
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
63% less funds holding
Funds holding: 80 → 30 (-50)
82% less capital invested
Capital invested by funds: $220M → $38.8M (-$181M)
96% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$184K |
| 2 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
+$89.9K |
| 3 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
+$39.9K |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$39.9K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$9.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$15M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$10.8M |
| 3 |
LA
Linden Advisors
New York
|
-$10M |
| 4 |
Goldman Sachs
New York
|
-$8.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.5M |
BIOSU Hedge Fund Activity: Q1 2022 in Review
30 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Unit (BIOSU) for Q1 2022, worth a combined $38.8M — down 82% from $220M a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of BIOSU and 2 opened new positions — a net loss of 50 holders — while 9 trimmed existing stakes and 5 added.
The largest buyer was State Street, opening a new position worth an estimated $184K. The largest seller was Saba Capital Management, exiting entirely with an estimated $15M sold.
- 30 institutional investors held BioPlus Acquisition Corp. Unit (BIOSU) as of Q1 2022, down from 80 in Q4 2021.
- Funds reported $38.8M of BioPlus Acquisition Corp. Unit stock for Q1 2022, down 82% quarter-over-quarter.
- 2 funds opened new BioPlus Acquisition Corp. Unit positions in Q1 2022 and 52 closed out, a net change of -50 holders.
- The largest BioPlus Acquisition Corp. Unit buyer in Q1 2022 was State Street, an estimated $184K added.
- The largest BioPlus Acquisition Corp. Unit seller in Q1 2022 was Saba Capital Management, an estimated $15M sold.
Based on aggregated 13F filings for Q1 2022.